← Leaderboards
Aimee S Payne
University Of Pennsylvania
$10,136,122
Attributed
$12,412,615
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,412,615 · 10
By mechanism
R01$8,710,242 · 4
P30$2,113,659 · 3
K08$638,145 · 1
UM1$550,569 · 1
R56$400,000 · 1
Top collaborators
- Amit Bar-Or5 shared
- Nicola J Mason5 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Roger J Pomerantz$8,125,354
- Marco Ruella$5,145,541
- Vijay Bhoj$3,391,776
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsB-LymphocytesPemphigus VulgarisSkinMediatingFutureAutoimmune DiseasesBullaTechnologyPemphigusInnovationInfectionAutoantibodiesKeratinocyteDisease RemissionSkin DisorderDesmogleinSerumAutoimmunitySafetyAntigensChronicFosteringPhenotype
Grant awards (45)
Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgaris$377,457
R01 · FY2025 · AR · contact PI
Skin Translational Research$125,674
P30 · FY2025 · AR · contact PI
Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgaris$369,009
R01 · FY2024 · AR · contact PI
Skin Translational Research$139,640
P30 · FY2024 · AR · contact PI
Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgaris$41,689
R01 · FY2024 · AR · contact PI
Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgaris$429,000
R01 · FY2023 · AR · contact PI
Skin Translational Research$139,640
P30 · FY2023 · AR · contact PI
University of Pennsylvania Clinical Autoimmunity Center of Excellence$78,890
UM1 · FY2023 · AI · contact PI
Translating cellular immunotherapies for autoimmunity to canine clinical trials$827,495
R01 · FY2022 · AR · contact PI
Skin Translational Research$139,640
P30 · FY2022 · AR · contact PI
University of Pennsylvania Clinical Autoimmunity Center of Excellence$78,890
UM1 · FY2022 · AI · contact PI
Translating cellular immunotherapies for autoimmunity to canine clinical trials$827,495
R01 · FY2021 · AR · contact PI
Skin Translational Research$139,640
P30 · FY2021 · AR · contact PI
University of Pennsylvania Clinical Autoimmunity Center of Excellence$78,890
UM1 · FY2021 · AI · contact PI
Translating cellular immunotherapies for autoimmunity to canine clinical trials$859,159
R01 · FY2020 · AR · contact PI
Skin Procurement and Engineering$153,924
P30 · FY2020 · AR · contact PI
University of Pennsylvania Clinical Autoimmunity Center of Excellence$78,890
UM1 · FY2020 · AI · contact PI
Translating cellular immunotherapies for autoimmunity to canine clinical trials$760,992
R01 · FY2019 · AR · contact PI
Engineering disease-specific T cells for pemphigus therapy$351,472
R01 · FY2019 · AR · contact PI
University of Pennsylvania Clinical Autoimmunity Center of Excellence$235,009
UM1 · FY2019 · AI · contact PI
Skin Procurement and Engineering$142,895
P30 · FY2019 · AR · contact PI
Translating cellular immunotherapies for autoimmunity to canine clinical trials$727,277
R01 · FY2018 · AR · contact PI
Engineering disease-specific T cells for pemphigus therapy$351,472
R01 · FY2018 · AR · contact PI
Skin Procurement and Engineering$154,029
P30 · FY2018 · AR · contact PI
Engineering disease-specific T cells for pemphigus therapy$351,472
R01 · FY2017 · AR · contact PI
Skin Procurement and Engineering$193,796
P30 · FY2017 · AR · contact PI
Engineering disease-specific T cells for pemphigus therapy$351,472
R01 · FY2016 · AR · contact PI
Skin Procurement and Engineering$204,936
P30 · FY2016 · AR · contact PI
Engineering disease-specific T cells for pemphigus therapy$351,472
R01 · FY2015 · AR · contact PI
Structure and Function of Human Pemphigus Autoantibodies$400,000
R56 · FY2014 · AR · contact PI
Role of autoantibody isotype in pemphigus pathogenesis$345,273
R01 · FY2014 · AR · contact PI
Role of autoantibody isotype in pemphigus pathogenesis$334,703
R01 · FY2013 · AR · contact PI
Tissue and Keratinocyte Procurement$113,583
P30 · FY2013 · AR · contact PI
Role of autoantibody isotype in pemphigus pathogenesis$342,085
R01 · FY2012 · AR · contact PI
Tissue and Keratinocyte Procurement$118,155
P30 · FY2012 · AR · contact PI
Role of autoantibody isotype in pemphigus pathogenesis$344,811
R01 · FY2011 · AR · contact PI
Cloning and characterization of human pemphigus autoantibodies$127,629
K08 · FY2011 · AR · contact PI
Tissue and Keratinocyte Procurement$118,154
P30 · FY2011 · AR · contact PI
Role of autoantibody isotype in pemphigus pathogenesis$366,437
R01 · FY2010 · AR · contact PI
Cloning and characterization of human pemphigus autoantibodies$127,629
K08 · FY2010 · AR · contact PI
Tissue and Keratinocyte Procurement$118,154
P30 · FY2010 · AR · contact PI
Cloning and characterization of human pemphigus autoantibodies$127,629
K08 · FY2009 · AR · contact PI
Tissue and Keratinocyte Procurement$111,799
P30 · FY2009 · AR · contact PI
Cloning and characterization of human pemphigus autoantibodies$127,629
K08 · FY2008 · AR · contact PI
Cloning and characterization of human pemphigus autoantibodies$127,629
K08 · FY2007 · AR · contact PI